EVOK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases...

Stats
Dagens volum	10 762.00
Gjennomsnittsvolum	40 632.00
Markedsverdi	4.12M
EPS	$-0.590 ( 2024-03-14 )
Neste inntjeningsdato	( $-0.210 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.210
ATR14	$0.0230 (4.60%)

Insider Trading

Date	Person	Action	Amount	type
2023-05-10	Widder Kenneth J	Buy	14 250	Stock Option (Right to Buy)
2023-05-10	Reed Vickie S	Buy	15 000	Stock Option (Right to Buy)
2023-05-10	Hill Malcolm R	Buy	14 625	Stock Option (Right to Buy)
2023-05-10	Garner Cam L	Buy	17 750	Stock Option (Right to Buy)
2023-05-10	Brady Todd C	Buy	14 625	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 99 transactions
Buy: 6 847 814 \| Sell: 1 253 905

Evoke Pharma Inc Korrelasjon

10 Mest positive korrelasjoner
EBIX	0.956
AGIL	0.954
RIDE	0.954
LGVN	0.953
DRMA	0.952
LMDX	0.951
VRAY	0.951
ASLE	0.951
VMAR	0.95
VVOS	0.946

10 Mest negative korrelasjoner
SGII	-0.966
NESR	-0.959
EGLE	-0.946
RNLC	-0.942
VMGA	-0.94
ADAL	-0.938
INBKZ	-0.938
KRUS	-0.934
ORTX	-0.933
SPLK	-0.932

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Evoke Pharma Inc Økonomi

Annual	2023
Omsetning:	$5.18M
Bruttogevinst:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2023
Omsetning:	$5.18M
Bruttogevinst:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2022
Omsetning:	$2.51M
Bruttogevinst:	$2.14M (85.24 %)
EPS:	$-2.60

FY	2021
Omsetning:	$1.62M
Bruttogevinst:	$1.29M (79.72 %)
EPS:	$-3.24

Financial Reports:

No articles found.

Evoke Pharma Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.